5GAC-SC: Global Advances and Controversies in Skin Cancer 2024

program AT A GLANCE

*this program is subject to change

Session Titles

  • Session 10.1 - Epidemiology, burden, risk (economics)

  • Session 10.2 - Epidermal Biology

  • Session 10.3 - Settings & Policy 3: Government

  • Session 11.1 - Personalised prevention and Interventions (genetics)

  • Session 11.2 - Immunology

  • Session 11.3 - AI and Technology

  • Session 14.1 - Organ Transplant Recipients

  • Session 14.2 - Pathology

  • Session 14.3 - Biology

  • Session 15.1 - Medical oncology - organ transplant recipients

  • Session 15.2 - Spatial Omics

  • Session 15.3 - Clinical

PROGRAM COMMITEE

  • Kiarash Khosrotehrani, University of Queensland

  • David Whiteman, QIMR Berghofer

  • Stuart MacGregor, QIMR Berghofer

  • Angela Webster, University of Sydney

  • Louisa Gordon, QIMR Berghofer

  • Charbel Darido, Peter MacCallum Cancer Centre

  • Scott Byrne, University of Sydney

  • Fiona Simpson, University of Queensland

  • Mark Shackleton, Monash University

  • Pascale Guitera, University of Sydney

  • Gabrielle Belz, University of Queensland

  • Arutha Kulasinghe, University of Queensland

  • Dougal Coates

  • Tavis Read, Princess Alexandra Hospital

  • Rahul Ladwa, Pricess Alexandra Hospital

  • Georgina Long, Melanoma Institute Australia

  • Angela Hong, University of Sydney

  • Marisu Rademaker, Auckland

  • Monika Janda, University of Queensland

  • James Wilmott, University of Sydney

  • Solange Green, Melanoma Centre Skin Cancer Clinic